Wells Fargo’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.6K Buy
3,079
+1,977
+179% +$40.9K ﹤0.01% 5616
2026
Q1
$18.9K Sell
1,102
-2,220
-67% -$45.7K ﹤0.01% 5794
2025
Q4
$77.6K Buy
3,322
+1,457
+78% +$37.6K ﹤0.01% 5466
2025
Q3
$59.2K Buy
1,865
+294
+19% +$8.88K ﹤0.01% 5507
2025
Q2
$44.6K Sell
1,571
-364
-19% -$10.9K ﹤0.01% 5547
2025
Q1
$59.7K Buy
1,935
+42
+2% +$1.43K ﹤0.01% 5339
2024
Q4
$62.8K Buy
1,893
+663
+54% +$22.5K ﹤0.01% 5408
2024
Q3
$37.2K Sell
1,230
-49
-4% -$1.53K ﹤0.01% 5454
2024
Q2
$36.1K Buy
1,279
+130
+11% +$4.08K ﹤0.01% 5405
2024
Q1
$42.5K Buy
1,149
+155
+16% +$5.79K ﹤0.01% 5323
2023
Q4
$40.9K Buy
994
+240
+32% +$7.7K ﹤0.01% 5349
2023
Q3
$23.5K Sell
754
-826
-52% -$32K ﹤0.01% 5533
2023
Q2
$63.4K Buy
1,580
+1,559
+7,424% +$63.8K ﹤0.01% 5307
2023
Q1
$866 Hold
21
﹤0.01% 6420
2022
Q4
$956 Buy
21
+1
+5% +$34 ﹤0.01% 6199
2022
Q3
$1K Buy
20
+1
+5% +$28 ﹤0.01% 6455
2022
Q2
$0 Buy
19
+3
+19% +$70 ﹤0.01% 7423
2022
Q1
$0 Hold
16
﹤0.01% 7742
2021
Q4
$0 Hold
16
﹤0.01% 7750
2021
Q3
$1K Sell
16
-1
-6% -$36 ﹤0.01% 6787
2021
Q2
$1K Hold
17
﹤0.01% 6728
2021
Q1
$1K Buy
17
+8
+89% +$277 ﹤0.01% 6763
2020
Q4
$0 Buy
+9
New +$354 ﹤0.01% 6967

Other funds holding SMTI

Wells Fargo's SMTI Position: Q2 2026 in Review

Wells Fargo increased its Sanara MedTech (SMTI) stake by 179% in Q2 2026, buying an estimated $40.9K and bringing the position to 3,079 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5616.

Wells Fargo first reported a position in SMTI in Q4 2020 and has held it in 23 quarters since. The position peaked at $77.6K in Q4 2025. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Wells Fargo held 3,079 shares of Sanara MedTech worth $72.6K as of Q2 2026.
  • Wells Fargo bought 1,977 Sanara MedTech shares in Q2 2026, an estimated $40.9K.
  • Sanara MedTech made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5616 holding.
  • Wells Fargo first reported a position in Sanara MedTech in Q4 2020 and has held it in 23 quarters since.
  • Wells Fargo's Sanara MedTech position peaked at $77.6K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.